...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Idea for Zenith
Reply New Message
Prev Message Back To Forum Threaded View Next Message

the "ZHCLF" shares trading on the OTC, do they carry with them the Resverlogix Royalty Preferred Shares that are entitled to dividends in the amount of 6-12 % of Resverlogix's net revenue if any.

Any shares that trade are just moving from one person to another so they would carry any rights with them.

 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply